| Concept of prevention. | I M Graham (Dublin, IE) | 30 Aug 2011 | Prevention and rehabilitation |
| dal-VESSEL: Efficacy and safety of dalcetrapib in patients with or at risk of coronary heart disease - the dal-VESSEL trial | T F Luescher (Zurich, CH) | 28 Aug 2011 | Prevention and rehabilitation |
| What to treat in diabetics: blood pressure, glucose or lipids. | T F Luescher (Zurich, CH) | 30 Aug 2011 | Prevention and rehabilitation |
| Cardiovascular prevention; a global problem. | U Keil (Muenster, DE) | 30 Aug 2011 | Prevention and rehabilitation |
| ASCOT: Anglo-Scandinavian Cardiac Outcomes Trial: 10 year follow-up of the Lipid_lowering Arml | P S Sever (London, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Discussant - dal-VESSEL: Efficacy and safety of dalcetrapib in patients with or at risk of coronary heart disease - the dal-VESSEL trial | K A A Fox (Edinburgh, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. | BA Kingwell (Melbourne, AU) | 29 Aug 2011 | Prevention and rehabilitation |
| Strategies for smoking cessation - evidence from trials. | D A Wood (London, GB) | 29 Aug 2011 | Prevention and rehabilitation |
| EUROACTION preventive cardiology programme plus intensive smoking cessation with Varenicline | D A Wood (London, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Introduction: coronary heart disease: from prevention to intervention | W Wijns (Aalst, BE) | 29 Aug 2011 | Prevention and rehabilitation |
| Discussant - ASCOT: Anglo-Scandinavian Cardiac Outcomes Trial: 10 year follow-up of the Lipid_lowering Arml | G De Backer (St Martens Latem, BE) | 28 Aug 2011 | Prevention and rehabilitation |
| Persistent smoking in high-risk patients - the reality in clinical practice and how to improve. | K Kotseva (London, GB) | 29 Aug 2011 | Prevention and rehabilitation |
| Primary results of the dal-PLAQUE study assessing the effect of dalcetrapib on structural and inflammatory atherosclerotic disease using non-invasive simultaneous multimodality imaging | Z A Fayad (New York, US) | 28 Aug 2011 | Prevention and rehabilitation |
| Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial | A Colombo (Milan, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| Polypill for secondary prevention. | V Fuster (New York, US) | 30 Aug 2011 | Prevention and rehabilitation |
| New strategies for resistant hypertension with metabolic syndrome. | F Mahfoud (Homburg/Saar, DE) | 30 Aug 2011 | Prevention and rehabilitation |
| Polypill for primary prevention. | S Yusuf (Hamilton, CA) | 30 Aug 2011 | Prevention and rehabilitation |
| J-Curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. | S Bangalore (New York, US) | 29 Aug 2011 | Prevention and rehabilitation |
| A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. | J Gomez Lara (St Cugat Del Valles, ES) | 29 Aug 2011 | Prevention and rehabilitation |
| Hypertension and diabetes in arabic countries. | M B Bdeir (Riyadh, SA) | 30 Aug 2011 | Prevention and rehabilitation |
| Alternatives to polypills. | AJ Taylor (Washington, US) | 30 Aug 2011 | Prevention and rehabilitation |
| How many life years still to be gained from prevention? | O H Franco Duran (Cambridge, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Microvessel disease in women. | N C Bairey Merz (Los Angeles, US) | 28 Aug 2011 | Prevention and rehabilitation |
| High risk - how to identify atherosclerosis. | H Li (Beijing, CN) | 30 Aug 2011 | Prevention and rehabilitation |
| C-Reactive Protein (CRP) can predict perioperative major cardiovascular events in patients undergoing noncardiac, nonvascular surgery | Murat Biteker (Istanbul, TR) | 28 Aug 2011 | Prevention and rehabilitation |
| Providing effective primary prevention to vulnerable communities: impact of a nurse-led, individual and community-based primary prevention program | M Carrington (Melbourne, AU) | 31 Aug 2011 | Prevention and rehabilitation |
| A sentinel opportunity to screen and improve cardiovascular risk in primary care: results of the anchor (a novel approach to cardiovascular health by optimizing risk management) study | J Cox (Halifax, CA) | 31 Aug 2011 | Prevention and rehabilitation |
| NT-proBNP plasma levels as a potential biomarker for cardiac damage after radiotherapy in left-sided breast cancer patients | M G Andreassi (Massa, IT) | 28 Aug 2011 | Prevention and rehabilitation |
| Project Raffaello: application and evaluation of the disease and care management approach in cardiovascular disease prevention | S Romano (L'aquila, IT) | 28 Aug 2011 | Prevention and rehabilitation |
| Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort : the suita study | H Arai (Kyoto, JP) | 28 Aug 2011 | Prevention and rehabilitation |
| On-treatment non-HDL cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: the JUPITER trial | S Mora (Boston, US) | 28 Aug 2011 | Prevention and rehabilitation |
| Randomized evaluation of the effects of a structured educational program (HERZ.LEBEN) on blood pressure in essential hypertensive patients | R Zweiker (Graz, AT) | 28 Aug 2011 | Prevention and rehabilitation |
| High-risk patients and guideline implementation | M Iurciuc (Timisoara, RO) | 28 Aug 2011 | Prevention and rehabilitation |
| What do general practitioners know about total cardiovascular risk assessment tool SCORE | MH Al Mohtaseb (Hafr, SA) | 28 Aug 2011 | Prevention and rehabilitation |
| Coronary heart disease treatment in Bulgaria - data from EUROASPIRE III trial | B Georgiev (Sofia, BG) | 28 Aug 2011 | Prevention and rehabilitation |
| Rapid reductions in left ventricular mass following a community based 12-week prevention programme are partially predicted by change in fat depots | S Jenni (London, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Ankle brachial index predicts one year mortality and cardiovascular events after non-cardiovascular major surgery. | P Lacroix (Limoges Cedex, FR) | 28 Aug 2011 | Prevention and rehabilitation |
| Impact of the implementation of worksite wellness program for cardiovascular disease prevention | E A Marsaro (Campinas, BR) | 28 Aug 2011 | Prevention and rehabilitation |
| Bayesian analysis of rosuvastatin in the prevention of cardiovascular disease | R Arora (North Chicago, US) | 28 Aug 2011 | Prevention and rehabilitation |
| Strategies to prevent and treat diabetes. | F A Al-Hussein (Riyadh, SA) | 30 Aug 2011 | Prevention and rehabilitation |
| Feasibility in the EUROACTION study. | C S Jennings (London, GB) | 29 Aug 2011 | Prevention and rehabilitation |
| Discussant - HCS: Prospective evaluation of post-prandial triglycerides and cardiovascular events in patients with coronary artery disease | P J Barter (Sydney, AU) | 28 Aug 2011 | Prevention and rehabilitation |
| Main stem stenoses should be treated interventionally. | P W Serruys (Rotterdam, NL) | 28 Aug 2011 | Prevention and rehabilitation |
| High-sensitivity troponin T predicts recurrent cardiovascular disease events in stable coronary heart disease patients: 8-year follow-up of the KAROLA study | W Koenig (Ulm, DE) | 31 Aug 2011 | Prevention and rehabilitation |
| Cardiac rehabilitation after acute myocardial infarction; effect on mortality, morbidity, medication and lifestyle changes | B Schwaab (Bernried, DE) | 29 Aug 2011 | Prevention and rehabilitation |
| Discussant - PURE: The prevention gaps in 17 low, middle and high income countries involving over 150,000 people | A P Maggioni (Florence, IT) | 28 Aug 2011 | Prevention and rehabilitation |
| The factors that influence pre hospital delay time in acute coronary syndrome patients | G McKee (Dublin, IE) | 28 Aug 2011 | Prevention and rehabilitation |
| EUROASPIRE III: modelling the clinical and cost-effectiveness of optimizing cardiovascular prevention in patients with established coronary heart disease in Europe | L Annemans (Gent, BE) | 28 Aug 2011 | Prevention and rehabilitation |
| Increasing circulating concentration of all HDL particle subclasses in hyper-responders: insights from the ASSERT study to apolipoprotein A-I induction | SJ Nicholls (Cleveland, US) | 31 Aug 2011 | Prevention and rehabilitation |
| Angiotensin-converting enzyme inhibitor therapy in nonobstructive coronary artery disease | O Manfrini (Bologna, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| The plasma level of B-type natriuretic peptide is a useful predictor of cardiac events for out-clinic patients with asymptomatic heart failure who are in a stable condition | M Yamaoka-Tojo (Sagamihara, JP) | 31 Aug 2011 | Prevention and rehabilitation |
| Effectiveness in the RESPONSE trial. | R J G Peters (Amsterdam, NL) | 29 Aug 2011 | Prevention and rehabilitation |
| Should we only focus on nurse-led programmes? | J Perk (Kalmar, SE) | 29 Aug 2011 | Prevention and rehabilitation |
| PURE: The prevention gaps in 17 low, middle and high income countries involving over 150,000 people | S Yusuf (Hamilton, CA) | 28 Aug 2011 | Prevention and rehabilitation |
| PURE: The prevention gaps in 17 low, middle and high income countries involving over 150,000 people | S Yusuf (Hamilton, CA) | 28 Aug 2011 | Prevention and rehabilitation |
| Most patients should be treated by drugs. | L Piegas (Sao Paulo, BR) | 28 Aug 2011 | Prevention and rehabilitation |
| Secondary prevention of high-risk patients with chronic coronary heart disease in the global STABILITY trial: excellent evidence-based therapy but improvement needed to reach goals | O Vedin (Uppsala, SE) | 29 Aug 2011 | Prevention and rehabilitation |
| Food supplementation with plant sterols is useful to prevent cardiovascular disease.: Contra. | O Weingaertner (Homburg/Saar, DE) | 28 Aug 2011 | Prevention and rehabilitation |
| All patients should be operated. | G D Dreyfus (Monaco, MC) | 28 Aug 2011 | Prevention and rehabilitation |
| Do we know how to do it? | N Houston-Miller (Stanford, US) | 29 Aug 2011 | Prevention and rehabilitation |
| HCS: Prospective evaluation of post-prandial triglycerides and cardiovascular events in patients with coronary artery disease | U Laufs (Homburg, DE) | 28 Aug 2011 | Prevention and rehabilitation |
| What is best for the patient? The individualised approach. | O R Coelho (Campinas, BR) | 28 Aug 2011 | Prevention and rehabilitation |
| Smoking relapse and mortality after acute coronary syndromes | F Colivicchi (Rome, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| Three-year Clinical Outcomes of the OLIVUS (Impact of OLmesartan on progression of coronary atherosclerosis; evaluation by IntraVascular UltraSound) trial | A Hirohata (Okayama, JP) | 29 Aug 2011 | Prevention and rehabilitation |
| Risk of cardiovascular outcomes after low-dose acetylsalicylic acid discontinuation: a UK primary care study | L A Garcia Rodriguez (Madrid, ES) | 29 Aug 2011 | Prevention and rehabilitation |
| High-risk single-nucleotide polymorphisms (SNPs) and genetic score on recurrent cardiovascular events following ischaemic heart disease | M G Andreassi (Massa, IT) | 31 Aug 2011 | Prevention and rehabilitation |
| Increasing levels of C-reactive protein are associated with accelerated progression of coronary atherosclerosis | K Uno (Cleveland, US) | 31 Aug 2011 | Prevention and rehabilitation |
| Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with dual antiplatelet therapy | S Solheim (Oslo, NO) | 31 Aug 2011 | Prevention and rehabilitation |
| The quality of cardiovascular care delivery in primary care in canada | C Liddy (Ottawa, CA) | 28 Aug 2011 | Prevention and rehabilitation |
| Blood pressure related risk for vascular events and mortality differs according to localization of vascular disease and presence of type 2 diabetes mellitus | J A N Dorresteijn (Utrecht, NL) | 28 Aug 2011 | Prevention and rehabilitation |
| Survival and quality of life 25 years after coronary artery bypass graft surgery | J Kakarla (Newcastle Upon Tyne, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Failure to attain low density lipoprotein cholesterol goal <70 mg/dL and loss of extra clinical benefit in very high risk stable coronary patients: a three year follow-up | L Rallidis (Argiroupolis, GR) | 28 Aug 2011 | Prevention and rehabilitation |
| Beta blocker therapy is associated with depressive symptoms 12 months post percutaneous coronary intervention | L C Battes (Gorinchem, NL) | 28 Aug 2011 | Prevention and rehabilitation |
| Risk factors control, treatment of atherothrombosis and habits of life in the secondary preventions of cardiovascular disease | E Otero Chulian (Cadiz, ES) | 28 Aug 2011 | Prevention and rehabilitation |
| Do cardiovascular patients with multivascular disease constitute an important clinical subgroup? | J Greenhalgh (Liverpool, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease | M Gulliksson (Uppsala, SE) | 29 Aug 2011 | Prevention and rehabilitation |
| Evaluation of safety and efficacy of Inocitol Hexanicotinic Acid (IHN) VS nicotinic acid in the treatment of dyslipidemia | P Kasetty (Bangalore, IN) | 29 Aug 2011 | Prevention and rehabilitation |
| Ageing and heart failure - similar mechanisms of exercise intolerance? | S Gielen (Leipzig, DE) | 29 Aug 2011 | Prevention and rehabilitation |
| New scientific advances in sports cardiology. | H Heidbuchel (Leuven, BE) | 29 Aug 2011 | Prevention and rehabilitation |
| Barriers to cardiac rehabilitation: does age make a difference? | N B Oldridge (Glendale, US) | 29 Aug 2011 | Prevention and rehabilitation |
| EUROACTION trial. | D A Wood (London, GB) | 29 Aug 2011 | Prevention and rehabilitation |
| New scientific advances in cardiac rehabilitation. | M F Piepoli (Piacenza, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| New scientific advances in exercise, basic and translational research. | V Adams (Leipzig, DE) | 29 Aug 2011 | Prevention and rehabilitation |
| Strategies to reduce barrier to referral. | T Jaarsma (Norrkoping, SE) | 29 Aug 2011 | Prevention and rehabilitation |
| Type-B natriuretic peptide and VE/VCO2 slope are reduced by low but not high intensity exercise training in chronic heart failure: a prospective randomized controlled study | A S Ferraz (Sao Paulo, BR) | 29 Aug 2011 | Prevention and rehabilitation |
| Sleep disorder, exercise capacity and endothelial function in Left Ventricle Assist Device implantation (LVAD) patients after Residential Cardiac Rehabilitation (RCR) | F Tarro Genta (Turin, IT) | 28 Aug 2011 | Prevention and rehabilitation |
| Cardiac rehabilitation in chronic heart failure: effect of aerobic interval training vs continuous training with regard to variables commonly used in clinical practice | C Freyssin (Sainte Clotilde, RE) | 29 Aug 2011 | Prevention and rehabilitation |
| Health-related quality of life in patients with coronary artery disease after coronary revascularization | I Tasic (Niska Banja, RS) | 29 Aug 2011 | Prevention and rehabilitation |
| Combined aerobic/ventilatory muscle training versus aerobic training in patients with chronic heart failure. The VENT-HEFT trial: A prospective randomized multi-european trial | I D Laoutaris (Athens, GR) | 28 Aug 2011 | Prevention and rehabilitation |
| Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. The ideal exercise program for CHF? | I D Laoutaris (Athens, GR) | 29 Aug 2011 | Prevention and rehabilitation |
| New scientific advances in prevention, epidemiology and population science. | D Vanuzzo (Udine, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| GOSPEL trial. | P Giannuzzi (Veruno, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| Effects of functional electrical stimulation on exercise capacity and quality of life in the elderly with heart failure | S Arapi (Athens, GR) | 28 Aug 2011 | Prevention and rehabilitation |
| Cardiac rehabilitation after transcatheter aortic valve implantation: a single centre experience | N Russo (Padova, IT) | 28 Aug 2011 | Prevention and rehabilitation |
| DANREHAB study. | ADO Zwisler (Hvalsoe, DK) | 29 Aug 2011 | Prevention and rehabilitation |
| Cardiac rehabilitation centre. | J-P Schmid (Bern, CH) | 29 Aug 2011 | Prevention and rehabilitation |
| Pathophysiology of exercise intolerance in the elderly. | D Leosco (Naples, IT) | 29 Aug 2011 | Prevention and rehabilitation |
| Older heart failure patients' preferences for cardiac rehabilitation service models | A Buttery (London, GB) | 28 Aug 2011 | Prevention and rehabilitation |
| Access to cardiac rehabilitation does not equate to attendance. | RA Clark (Brisbane, AU) | 28 Aug 2011 | Prevention and rehabilitation |
| A cardiac rehabilitation model applied to patients with non-disabling stroke. Sustained benefits at one year in the community cardiovascular hearts in motion program. | N Giacomantonio (Halifax, CA) | 28 Aug 2011 | Prevention and rehabilitation |
| Inspiratory muscle training reduces blood pressure and sympathetic activity in hypertensive patients: a randomized controlled trial | P Dall'Ago (Porto Alegre, BR) | 29 Aug 2011 | Prevention and rehabilitation |
| Preoperative respiratory muscle training reduces complications in coronary artery bypass surgery | T Carvalho (Florianopolis, BR) | 29 Aug 2011 | Prevention and rehabilitation |
| Changes in erectile dysfunction and arterial stiffness following cardiac rehabilitation a clinical research study | J Radhakrishnan (Greater London, GB) | 29 Aug 2011 | Prevention and rehabilitation |
| Aerobic exercise training reduces the perfusion defects and angina in patients with coronary microvascular ischemia | MV Simoes (Ribeirao Preto, BR) | 29 Aug 2011 | Prevention and rehabilitation |
| Nutritional education during a cardiac rehabilitation programme : positive effects at six months | B Pavy (Machecoul, FR) | 29 Aug 2011 | Prevention and rehabilitation |
| Does red blood cell width affect functional capacity recovery in patients attending cardiac rehabilitation after ACS? | C Castanheira De Sousa (Valbom, Gondomar, PT) | 29 Aug 2011 | Prevention and rehabilitation |